Artiss

Name: Artiss

What is the most important information I should know about fibrin sealant topical?

You should not be treated with fibrin sealant topical if you are allergic to cows or products made from cows.

What happens if I overdose?

Since this medicine is applied by a healthcare professional in a medical setting, an overdose is unlikely to occur.

Commonly used brand name(s)

In the U.S.

  • Artiss
  • Tisseel

Available Dosage Forms:

  • Solution

Nonclinical Toxicology

Carcinogenesis, Mutagenesis, Impairment of Fertility

Long-term animal studies to evaluate the carcinogenic potential of Artiss or studies to determine the effect of Artiss on fertility have not been performed.

How Supplied/Storage and Handling

Artiss is supplied in the following pack sizes and presentations:

Table 4.
Pack Size NDC Number
Artiss Kit (Freeze-Dried) Artiss Kit (Freeze-Dried) with DUPLOJECT System Artiss Pre-Filled Syringe (Frozen) with DUO Set
2 mL 0944-4351-03 0944-4351-04 0944-8503-02
4 mL 0944-4351-07 0944-4351-08 0944-8503-04
10 mL 0944-4351-11 0944-4351-12 0944-8503-10

See DOSAGE FORMS AND STRENGTHS, Package Contents (3.2).

Storage

Store Artiss in original carton to protect from light.

Artiss Kit (Freeze-Dried)

Store at 2°C to 25°C. Avoid freezing. After reconstitution, the product must be used within 4 hours. Reconstituted solutions must not be refrigerated or frozen.

Artiss Pre-filled Syringe (Frozen)

Long term: Store at ≤ -20°C.
Short term: Room Temperature Thawing: Unopened pouches, thawed at room temperature, may be stored for up to 14 days at room temperature (15-25°C) after removal from the freezer.
Quick Thawing: Maintain the product at 33-37°C until use. If the product is removed from original pouch or warmed to 33-37°C it must be used within 12 hours.
Do not refrigerate or re-freeze after thawing. Do not microwave.

Do not use after the expiration date. Discard if packaging of any components is damaged.

Principal Display Panel

Artiss 4 mL kit unit carton

NDC 0944-4351-07

4 mL

Kit

Fibrin Sealant (Human)

Artiss

Contents:

Sealer Protein Concentrate (Human). Vapor Heated, Solvent/Detergent Treated, freeze dried, sterile, for 2 mL of Sealer Protein Solution

Fibrinolysis Inhibitor Solution (Synthetic), Sterile, 3000 KIU of Aprotinin/mL

Thrombin (Human), Vapor Heated, Solvent/Detergent Treated, freeze dried, sterile, for 2 mL of Thrombin Solution 4 IU/mL

Calcium Chloride Solution. Sterile, 40 µmol/mL

FOR TOPICAL USE ONLY

NOT FOR INJECTION

Do not use on individuals with a know hypersensitivity to aprotinin. The risk and benefits of this product should be discussed with the patient. Read the full prescribing information before use.

For single use only.

No preservative

Latex free

Rx Only

Baxter

Artiss 4 mL kit sleeve

NDC 0944-4351-08

4 mL

Kit

Fibrin Sealant (Human)

Artiss

Contents:

Sealer Protein Concentrate (Human). Vapor Heated, Solvent/Detergent Treated, freeze dried, sterile, for 2 mL of Sealer Protein Solution

Fibrinolysis Inhibitor Solution (Synthetic), Sterile, 3000 KIU of Aprotinin/mL

Thrombin (Human), Vapor Heated, Solvent/Detergent Treated, freeze dried, sterile, for 2 mL of Thrombin Solution 4 IU/mL

Calcium Chloride Solution. Sterile, 40 µmol/mL

Also includes: DUPLOJECT System for Artiss [Fibrin Sealant (Human)] 2mL/4mL

FOR TOPICAL USE ONLY

NOT FOR INJECTION

Do not use on individuals with a know hypersensitivity to aprotinin. The risk and benefits of this product should be discussed with the patient. Read the full prescribing information before use.

For single use only.

No preservative

Latex free

Rx Only

Baxter

Sealer Protein Concentrate (Human) vial label

NDC 0944-7112-02

Sealer Protein Concentrate (Human)

Baxter

Vapor Heated, Solvent/Detergent Treated, Freeze-Dried, Sterile

Reconstitute with 2 mL of Fibrinolysis Inhibitor Solution (Synthetic)

Vial contains a stirrer to facilitate reconstitution.

Baxter Healthcare Corporation

Westlake Village, CA 91362 USA

U.S. License No. 140

Use within 4 hours of reconstitution.

Read enclosed directions prior to use.

NOT FOR INJECTION.

Store at 2ºC to 25ºC.

Rx only

Thrombin (Human) vial label

NDC 0944-7344-02

Thrombin (Human)

Baxter

Vapor Heated, Solvent/Detergent Treated, Freeze-Dried, Sterile

Reconstitute with 2 mL of Calcium Chloride Solution

Concentration: 4 IU/mL

Baxter Healthcare Corporation

Westlake Village, CA 91362 USA

U.S. License No. 140

Rx Only

Use within 4 hours of reconstitution.

Read enclosed directions prior to use.

NOT FOR INJECTION.

Store at 2ºC to 25ºC.

Calcium Chloride Solution vial label

NDC 0944-7401-02

Calcium Chloride Solution

Baxter

Sterile For reconstitution of freeze-dried Thrombin (Human), Contents: 2 mL

Concentration: 40 µmol/mL

NOT FOR INJECTION. Store at 2°C to 25°C.

Baxter Healthcare Corporation

Westlake Village, CA 91362 USA

U.S. License No. 140

Rx Only

Fibrinolysis Inhibitor Solution (Synthetic) vial label

NDC 0944-7201-01

Fibrinolysis Inhibitor Solution (Synthetic)

Baxter

Sterile For reconstitution of freeze-dried Sealer Protein Concentrate (Human), Contents: 1 mL

Concentration: 3000 KIU of Aprotinin/mL

NOT FOR INJECTION. Store at 2°C to 25°C.

Baxter Healthcare Corporation

Westlake Village, CA 91362 USA

U.S. License No. 140

Rx Only

Artiss Frozen 4 mL unit carton

NDC 0944-8503-04

4 mL

Fibrin Sealant (Human)

Artiss

Frozen

TOPICAL USE ONLY

DO NOT INJECT

Contents:

Pre-filled syringe containing:

Sealer Protein Solution (1): 2 mL, sterile

Sealer Protein (Human) Vapor Heated, Solvent /Detergent Treated

Fibrinolysis Inhibitor (Aprotinin, Synthetic), 3000 KIU/mL

Thrombin Solution (2): 2 mL, sterile

Thrombin (Human), 4 units/mL Vapor Heated, Solvent /Detergent Treated

Calcium Chloride, 40 µmol/mL

Do not use on individuals with a known hypersensitivity to aprotinin and/or any of the active substances or excipients.

The risks and benefits of this product should be discussed with the patient.

Read full prescribing information before use.

Store at -20°C (-4°F) or colder. Unopened pouches, thawed at room temperature, may be stored for up to 14 days at 15-25°C.

The product must be used within 12 hours after warming to 33-37°C or removal form original pouches.

Do not refrigerate, microwave, or re-freeze.

For single use only

No preservative

Latex free

Rx Only

Contents were sterilized and package under aseptic conditions.

Artiss Frozen 4 mL pouch label

NDC 0944-8503-04

Fibrin Sealant (Human)

Artiss 4 mL

Frozen

Baxter

Contents:

Pre-filled syringe containing:

Sealer Protein Solution (1): 2 mL, sterile

Sealer Protein (Human)

Fibrinolysis Inhibitor (Aprotinin, Synthetic), 3000 KIU/mL

Thrombin Solution (2): 2 mL, sterile

Thrombin (Human), 4 units/mL

Calcium Chloride, 40 µmol/mL

Read directions for thawing and application before use.

TOPICAL USE ONLY

DO NOT INJECT

Store at -20°C (-4°F) or colder. Unopened pouches, thawed at room temperature, may be stored for up to 14 days at 15-25°C.

Do not refrigerate, microwave, or re-freeze.

Rx Only

Contents were sterilized and package under aseptic conditions.

Baxter Healthcare Corporation

Westlake Village, CA 91362 USA

U.S. License No. 140

Rx Only

Artiss 4 mL Syringe label

Baxter

Fibrin Sealant (Human)

Artiss

4 mL

Artiss 
fibrinogen human thrombin human kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0944-4351
Packaging
# Item Code Package Description
1 NDC:0944-4351-07 1 KIT (KIT) in 1 CARTON
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 VIAL, GLASS 2 mL
Part 2 1 VIAL, GLASS 2 mL
Part 3 1 VIAL, GLASS 2 mL
Part 4 1 VIAL, GLASS 2 mL
Part 1 of 4
SEALER PROTEIN CONCENTRATE HUMAN 
fibrinogen human powder, for solution
Product Information
Item Code (Source) NDC:0944-7112
Route of Administration TOPICAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FIBRINOGEN (FIBRINOGEN) FIBRINOGEN 90 mg  in 1 mL
Inactive Ingredients
Ingredient Name Strength
ALBUMIN (HUMAN)  
HISTIDINE  
NIACINAMIDE  
POLYSORBATE 80  
TRISODIUM CITRATE DIHYDRATE  
Packaging
# Item Code Package Description
1 NDC:0944-7112-02 2 mL in 1 VIAL, GLASS
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA125266 01/11/2011
Part 2 of 4
THROMBIN HUMAN 
thrombin human powder, for solution
Product Information
Item Code (Source) NDC:0944-7344
Route of Administration TOPICAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
THROMBIN HUMAN (THROMBIN HUMAN) THROMBIN HUMAN 4 [iU]  in 1 mL
Inactive Ingredients
Ingredient Name Strength
ALBUMIN (HUMAN)  
SODIUM CHLORIDE  
Packaging
# Item Code Package Description
1 NDC:0944-7344-02 2 mL in 1 VIAL, GLASS
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA125266 01/11/2011
Part 3 of 4
FIBRINOLYSIS INHIBITOR SOLUTION 
aprotinin liquid
Product Information
Item Code (Source) NDC:0944-7201
Route of Administration TOPICAL DEA Schedule     
Inactive Ingredients
Ingredient Name Strength
APROTININ 3000 [iU]  in 1 mL
WATER  
Packaging
# Item Code Package Description
1 NDC:0944-7201-02 2 mL in 1 VIAL, GLASS
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA125266 01/11/2011
Part 4 of 4
CALCIUM CHLORIDE SOLUTION 
calcium chloride liquid
Product Information
Item Code (Source) NDC:0944-7401
Route of Administration TOPICAL DEA Schedule     
Inactive Ingredients
Ingredient Name Strength
CALCIUM CHLORIDE 40 umol  in 1 mL
Packaging
# Item Code Package Description
1 NDC:0944-7401-02 2 mL in 1 VIAL, GLASS
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA125266 01/11/2011
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA125266 01/11/2011
Artiss  FROZEN
fibrinogen human thrombin human solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:0944-8503
Route of Administration TOPICAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FIBRINOGEN (FIBRINOGEN) FIBRINOGEN 90 mg  in 1 mL
THROMBIN HUMAN (THROMBIN HUMAN) THROMBIN HUMAN 4 [iU]  in 1 mL
Inactive Ingredients
Ingredient Name Strength
APROTININ 3000 [iU]  in 1 mL
CALCIUM CHLORIDE 40 umol  in 1 mL
ALBUMIN (HUMAN)  
TRISODIUM CITRATE DIHYDRATE  
HISTIDINE  
NIACINAMIDE  
POLYSORBATE 80  
SODIUM CHLORIDE  
WATER  
Packaging
# Item Code Package Description
1 NDC:0944-8503-04 1 SYRINGE, PLASTIC (SYRINGE) in 1 CARTON
1 4 mL in 1 SYRINGE, PLASTIC
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA125266 01/11/2011
Labeler - Baxter Healthcare Corporation (039121363)
Establishment
Name Address ID/FEI Operations
Baxter Innovations GmbH 300178716 MANUFACTURE
Revised: 12/2010   Baxter Healthcare Corporation

Liver Dose Adjustments

Data not available

Dialysis

Data not available

Other Comments

To prevent fibrin sealant topical from adhering to gloves and instruments, wet with saline before contact with product.

Fibrin sealant topical Breastfeeding Warnings

There are no data on the excretion of fibrin sealant topical into human milk. Because many drugs are excreted in human milk, caution is recommended when fibrin sealant topical is administered to a lactating woman.

(web3)